Literature DB >> 15958456

Gene profile and response to treatment.

J Smeds1, L D Miller, J Bjöhle, P Hall, S Klaar, E T Liu, Y Pawitan, A Ploner, J Bergh.   

Abstract

Mesh：

Year:  2005        PMID： 15958456     DOI： 10.1093/annonc/mdi737

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis.

Authors:  Guosong Shen; Pingya He; Yingying Mao; Peipei Li; Frank Luh; Guohui Ding; Xiyong Liu; Yun Yen
Journal:  J Breast Cancer       Date:  2017-06-26       Impact factor: 3.588

3.  An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.

Authors:  Dan Xue; Pu Cheng; Mengjiao Han; Xiyong Liu; Lijun Xue; Chenyi Ye; Ke Wang; Jian Huang
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

4.  Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.

Authors:  Benfang Wang; Jianjiang Yu; Zhenjiang Sun; Frank Luh; Dandan Lin; Ying Shen; Ting Wang; Qi Zhang; Xiyong Liu
Journal:  Mol Carcinog       Date:  2020-04-29       Impact factor: 4.784

5.  Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.

Authors:  Hang Zhang; Xiyong Liu; Charles D Warden; Yasheng Huang; Sofia Loera; Lijun Xue; Suzhan Zhang; Peiguo Chu; Shu Zheng; Yun Yen
Journal:  BMC Cancer       Date:  2014-09-11       Impact factor: 4.430

6.  Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.

Authors:  Lahong Zhang; Zhaojun Chen; Dan Xue; Qi Zhang; Xiyong Liu; Frank Luh; Liquan Hong; Hang Zhang; Feng Pan; Yuhua Liu; Peiguo Chu; Shu Zheng; Guoqiang Lou; Yun Yen
Journal:  Oncol Rep       Date:  2016-09-20       Impact factor: 3.906
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.